Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Omalizumab biosimilar for treating chronic spontaneous urticaria	Omalizumab biosimilar	Chronic spontaneous urticaria (CSU)	Dermatology	2023	View \| Download
Olorofim for invasive fungal infections	Olorofim	Fungal infections	Infectious Disease	2023	View \| Download
Ocrelizumab (subcutaneous) for the treatment of primary progressive or relapsing multiple sclerosis	Ocrelizumab (Ocrevus;2H7v114)	Multiple sclerosis (MS)	Neurology	2023	View \| Download
Obinutuzumab with mycophenolate mofetil for treating lupus nephritis	Mycophenolate mofetil (Cellcept) , Obinutuzumab (Gazyvaro; RO5072759; GA101; Afutuzumab)	Lupus nephritis	Immunology , Nephrology	2023	View \| Download
Obecabtagene autoleucel for treating refractory or relapsed B cell acute lymphoblastic leukaemia	Obecabtagene autoleucel	Acute lymphoblastic leukaemia (ALL)	Haematological Cancer and Lymphomas	2023	View \| Download
NVK-002 for myopia in children	NVK-002	Myopia	Ophthalmology	2023	View \| Download
Nivolumab adjuvant therapy for renal cell carcinoma	Nivolumab (Opdivo; BMS-936558; ONO-4538)	Renal cell carcinoma (RCC)	Renal Cancer	2023	View \| Download
Niraparib with pembrolizumab maintenance therapy for metastatic stage III or IV non-small cell lung cancer	Niraparib (Zejula; MK 4827; JNJ 64091742; GSK 3985771; niraparib tosylate monohydrate) , Pembrolizumab (Keytruda; MK-3475)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Niraparib as maintenance therapy for treating recurrent or primary-advanced endometrial cancer after chemotherapy in combination with dostarlimab.	Chemotherapy , Dostarlimab (TSR-042; Jemperli) , Niraparib (Zejula; MK 4827; JNJ 64091742; GSK 3985771; niraparib tosylate monohydrate)	Endometrial cancer	Female Reproductive Cancer	2023	View \| Download
Nipocalimab for Generalised Myasthenia Gravis	Nipocalimab	Myasthenia gravis (MG)	Musculoskeletal System	2023	View \| Download